Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Lutetium-177 LNC1004 in Cancer Treatment | Open Medscience
177Lu-LNC1004 Radioligand Therapy in Patients with End-stage Metastatic ...
诊断到治疗，蓝纳成新核药加速临床转化，推动精准诊疗一体化进程 - 知乎
Fibroblast Activation Protein-Targeted Radioligand Therapy with 177Lu ...
集团新闻 - 烟台东诚药业集团股份有限公司
厦门大学附属第一医院核医学科陈皓鋆团队Clin Cancer Res: 177Lu-EB-FAPI放射配体治疗为晚期碘难治性甲癌治疗提供新策略 ...
Sequential 177Lu/225Ac-LNC1004 targeted radionuclide therapy with anti ...
Development of [177Lu]Lu-LNC1003 for radioligand therapy of prostate ...
Treatment Outcome and Predictive Factors for Radioligand Therapy with ...
Development of dual targeting heterodimer 177Lu-LNC1009 for cancer ...
Lu-177-LNC1004 - Oncidium Foundation
177Lu-LNC1004(177Lu-LNC1004) - 药物靶点：FAP_在研适应症：分化型甲状腺癌，难治性甲状腺癌，晚期恶性实体瘤 ...
First-In-Human Results on the Biodistribution, Pharmacokinetics, and ...
JNM | 一种可以提高肿瘤摄取和滞留的FAP靶向新型小分子放射性偶联物二聚体 - 中国核技术网
Molecular imaging and biochemical response assessment after a single ...
(177Lu-LNC1004)-药物靶点：FAP_在研适应症：实体瘤_专利_临床_研发
(PDF) Fibroblast Activation Protein-Targeted Radioligand Therapy with ...
Fibroblast activation protein targeted radioligand therapy enhances the ...
Preclinical Evaluation of a New Series of Albumin-Binding 177Lu-Labeled ...
Rational Design and Preliminary Evaluation of a Radiopharmaceutical ...
荧光探针-第3页-西安齐岳生物
Development of 177Lu/225Ac-LNC1003 for the radioligand therapy of ...
Yantai Dongcheng Pharma Secures FDA Fast-Track Designation for 177Lu ...
Preclinical evaluation of FAP-2286 for fibroblast activation protein ...
Radioimmunotherapy of Fibroblast Activation Protein Positive Tumors by ...
同位素材料联合实验室开工 - 中国核技术网
Radioligands Targeting Fibroblast Activation Protein (FAP)
全新靶点肿瘤治疗放射性药物临床试验获批 - 中国核技术网
Evans blue-modified radiolabeled fibroblast activation protein ...
作为靶向前列腺特异性膜抗原的治疗性放射性药物的177Lu-DOTA-HYNIC-iPSMA的制作方法
Clinical Cancer Research | American Association for Cancer Research
89Zr/177Lu-FAPI-TZ 的设计、合成和临床前评估：靶向成纤维细胞激活蛋白的潜在治疗对,Bioconjugate ...
【福建】177Lu-EB-FAPI（LNC1004）放射配体治疗为晚期碘难治性甲癌治疗提供新策略_研究_肿瘤_药物
Theranostics Targeting Fibroblast Activation Protein in the Tumor ...
Design and validation of fibroblast activation protein alpha targeted ...
Antitumor Efficacy and Potential Mechanism of FAP-targeted Radioligand ...
Preparation and Bioevaluation of 99mTc-Labeled FAP Inhibitors as Tumor ...
Slide 11
抗癌核药产品177Lu-LNC1004注射液治疗放射性碘难治性甲状腺癌_患者_肿瘤_剂量
177Lu-LNC1004 Radioligand Therapy in Patients with End-Stage Metastatic ...
全新FAP靶点放射性药物！前沿新药177Lu-LNC1004注射液给实体瘤患者带来新希望 - 知乎
日本放射治疗回顾：从粒子治疗(质子、碳离子、硼中子俘获治疗)谈起(一) - 中国核技术网
slide30
JCI - Targeting tumor-associated fibroblasts improves cancer ...
Fibroblast Activation Protein–Targeted Radioligand Therapy for ...
Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide ...
Preclinical Evaluation of 177Lu-OncoFAP-23, a Multivalent FAP-Targeted ...
177Lu-Labeled Bivalent Ligands of Prostate-Specific Membrane Antigen ...
Figure 4 from Theranostics Targeting Fibroblast Activation Protein in ...
东诚药业最新公告：177Lu-LNC1004注射液药物临床试验获批_数据_资金_公司
Mediso - Evans blue-modified radiolabeled fibroblast activation protein ...
FAP-4-1BBL targets to FAP + tumor tissue and LN in a CRC-bearing rhesus ...
Antitumor efficacy and potential mechanism of FAP-targeted radioligand ...
Targeting the Tumor Microenvironment with Fluorescence-Activatable ...
诺华前列腺癌放射靶向药物镥[177Lu]特昔维匹肽国内获批——药研快讯
重磅 | 177Lu - LNC1004注射液获得美国FDA快速通道资格认定医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
东诚药业子公司蓝纳成生物在2023年北美核医学与分子影像学会年会闪耀 - 中国核技术网
Tumor Suppression by Anti-Fibroblast Activation Protein Near-Infrared ...
Tumor-targeted 4-1BB agonists for combination with T cell bispecific ...
FAP-targeted radioligand therapy with 68Ga/177Lu-DOTA-2P(FAPI)2 enhance ...
Abstract LBA032: Pan-cancer analysis of fibroblast activation protein ...
(PDF) Theranostics Targeting Fibroblast Activation Protein in the Tumor ...
蓝纳成在核素诊疗领域的创新研究成果受到国际同行关注 - 知乎
Adjuvant effect of lncRNAs on chemotherapy. A. LINC01714 can enhance ...
Development of 177Lu‑LNC1010 for Peptide Receptor Radionuclide Therapy ...
Effective Immunoconjugate Therapy in Cancer Models Targeting a Serine ...
一篇讲明白177Lu-TBM治疗骨转移|靶向治疗|骨转移瘤|药物|177Lu|-健康界
177Lu-LNC1004注射液将于近期开展临床试验_财富号_东方财富网
177Lu-PSMA放射性配体治疗高龄mCRPC患者 - 中国核技术网
Targeting LINC01711 in FAP+ cancer-associated fibroblasts overcomes ...
FAP targeted radiotherapy induces an immunogenic tumor microenvironment ...
Theranostic Potential of [68Ga]Ga/[177Lu]Lu-LNC1013: A Dual-Purpose ...
大环螯合剂功能化177Lu-DTPA-Bz-Cys-RGD dimer偶联镥核素-多肽 - 知乎
EJNMMI|在胰腺癌模型中比较[177Lu]FAPI-46与[225Ac]FAPI-46的肿瘤治疗效果 - 中国核技术网
Full article: Long intergenic non-protein coding RNA 1094 (LINC01094 ...
Pharmacokinetics and Toxicology of a Fibroblast Activation Protein (FAP ...
【化学生物学】用类肽残基重新构建胶原三螺旋_N-gly
东诚药业子公司蓝纳成生物在2023年北美核医学与分子影像学会年会闪耀_财富号_东方财富网
A molecule inducing androgen receptor degradation and selectively ...
Tumor-Targeted Interleukin 2 Boosts the Anticancer Activity of FAP ...
